Delayed diagnosis is influenced by the clinical pattern of Crohn's disease and affects treatment outcomes and quality of life in the long term: A cross-sectional study of 361 patients in Southern Italy

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 2, 2015, Pages 175-181

  Pellino, Gianluca ^a   Sciaudone, Guido ^a   Selvaggi, Francesco ^a   Riegler, Gabriele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Crohn's disease; diagnosis; diagnostic delay; inflammatory bowel disease; quality of life; surgery

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DELAYED DIAGNOSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; ITALY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; TREATMENT OUTCOME; ADOLESCENT; KAPLAN MEIER METHOD; MIDDLE AGED; PROGNOSIS; RECURRENT DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84920286024     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000244     Document Type: Article

References (47)

1. Latella G, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G, et al. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. J Crohns Colitis 2014; 8:1147-1165
2. Canani RB, Cirillo P, Mallardo G, Buccigrossi V, Secondo A, Annunziato L, et al. Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology 2003; 124:368-376
3. Papi C, Festa V, Fagnani C, Stazi A, Antonelli G, Moretti A, et al. Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Dig Liver Dis 2005; 37:247-253
4. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975; 68:627-635
5. Farmer RG, Whelan G, Fazio VW. Long-Term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88:1818-1825
6. Sachar DB, Andrews HA, Farmer RG. Proposed classification of patients subgroups in Crohn's disease. Gastroenterol Int 1992; 5:142-154
7. Louis E, Reenaers C, Belaiche J. Does the behavior of Crohn's disease change over time?. Inflamm Bowel Dis 2008; Suppl 2:S54-S55
8. Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, et al. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - An IG-IBD study. Am J Gastroenterol 2005; 100:84-92
9. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol 2003; 98:363-368
10. Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. World J Gastroenterol 2009; 15:3504-3510
11. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for theWorld Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6:8-15
12. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; Suppl A: 5A-36A.
13. Louis E, Reenaers C, Belaiche J. Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn's disease?. Inflamm Bowel Dis 2008; Suppl 2:S59-S60
14. Selvaggi F, Sciaudone G, Limongelli P, Di Stazio C, Guadagni I, Pellino G, et al. The effect of pelvic septic complications on function and quality of life after ileal pouch-Anal anastomosis: a single center experience. Am Surg 2010; 76:428-435
15. Pellino G, Sciaudone G, Candilio G, Camerlingo A, Marcellinaro R, Rocco F, et al. Complications and functional outcomes of restorative proctocolectomy for ulcerative colitis in the elderly. BMC Surg 2013; Suppl 2:S9
16. Pellino G, Sciaudone G, Candilio G, Campitiello F, Selvaggi F, Canonico S. Effects of a new pocket device for negative pressure wound therapy on surgical wounds of patients affected with Crohn's disease: a pilot trial. Surg Innov 2014; 21:204-212
17. Pellino G, Sciaudone G, Miele E, Candilio G, De Fatico GS, Riegler G, et al. Functional outcomes and quality of life after restorative proctocolectomy in paediatric patients: a case-control study. Gastroenterol Res Pract 2014; 2014:340341
18. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, et al. European Crohn's and Colitis Organisation (ECCO). The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4:7-27
19. Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, et al. European Crohn's and Colitis Organisation. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7:982-1018
20. Cappabianca S, Granata V, Di Grezia G, Mandato Y, Reginelli A, Di Mizio V, et al. The role of nasoenteric intubation in the MR study of patients with Crohn's disease: our experience and literature review. Radiol Med 2011; 116:389-406
21. Ciccocioppo R, Klersy C, Russo ML, Valli M, Boccaccio V, Imbesi V, et al. Validation of the Italian translation of the Inflammatory Bowel Disease Questionnaire. Dig Liver Dis 2011; 43:535-541
22. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut 2010; 59:141-147
23. Latiano A, Palmieri O, Cucchiara S, Castro M, D'Incà R, Guariso G, et al. Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol 2009; 104:110-116
24. Tang LY, Rawsthorne P, Bernstein CN. Are perineal and luminal fistulas associated in Crohn's disease?. A population-based study. Clin Gastroenterol Hepatol 2006; 4:1130-1134
25. Zabana Y, Garcia-Planella E, van Domselaar M, Mañosa M, Gordillo J, López-Sanromán A, et al. Predictors of favourable outcome in inflammatory Crohn's disease. A retrospective observational study. Gastroenterol Hepatol 2013; 36:616-623
26. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999; 13:1403-1411
27. Zabana Y, Garcia-Planella E, Van Domselaar M, Mañosa M, Gordillo J, López San Román A, et al. Does active smoking really influence the course of Crohn's disease?. A retrospective observational study. J Crohns Colitis 2013; 7:280-285
28. Sciaudone G, Pellino G, Riegler G, Selvaggi F. Infliximab in drug-naïve patients with failed ileorectal anastomosis for Crohn's disease: a new chance for sparing the rectum?. Eur Surg Res 2011; 46:163-168
29. Sciaudone G, Di Stazio C, Limongelli P, Guadagni I, Pellino G, Riegler G, et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg 2010; 53:299-304
30. Musto D, Martorelli L, Cirillo A, Selvaggi F, Esposito P, Russo MI, Riegler G. Distal esophageal involvement in Crohn disease: short treatment with adalimumab. Endoscopy 2010; Suppl 2:E299
31. Siassi M, Weiger A, Hohenberger W, Kessler H. Changes in surgical therapy for Crohn's disease over 33 years: a prospective longitudinal study. Int J Colorectal Dis 2007; 22:319-324
32. Gao X, Yang RP, Chen MH, Xiao YL, He Y, Chen BL, Hu PJ. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease. Scand J Gastroenterol 2012; 47:1181-1191
33. Selvaggi F, Sciaudone G, Giuliani A, Limongelli P, Di Stazio C. A new type of strictureplasty for the treatment of multiple long stenosis in Crohn's disease. Inflamm Bowel Dis 2007; 13:641-642
34. Yamamoto T. Conventional vs nonconventional strictureplasties for Crohn's disease. Dis Colon Rectum 2012; 55:e365; author reply e365-366
35. Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J, Jess T. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 2014; 63:1607-1616
36. Magro F, Rodrigues-Pinto E, Coelho R, Andrade P, Santos-Antunes J, Lopes S, et al. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators?. Predictive factors of phenotype progression. Am J Gastroenterol 2014; 109:1026-1036
37. Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol 2009; 104:2754-2759
38. Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, et al. PRO-KIIDS Research Group. Increased effectiveness of early therapy with anti-Tumor necrosis factor-Á vs an immunomodulator in children with Crohn's disease. Gastroenterology 2014; 146:383-391
39. Markowitz J. Can we change the natural history of Crohn's disease with early immunomodulation?. Dig Dis 2014; 32:345-350
40. Spradlin NM, Wise PE, Herline AJ, Muldoon RL, Rosen M, Schwartz DA. A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. Am J Gastroenterol 2008; 103:2527-2535
41. Falconi M, Pederzoli P. The relevance of gastrointestinal fistulae in clinical practice: a review. Gut 2001; Suppl 4:iv2-iv10
42. Scharl M, Frei P, Frei SM, Biedermann L, Weber A, Rogler G. Epithelial-Tomesenchymal transition in a fistula-Associated anal adenocarcinoma in a patient with long-standing Crohn's disease. Eur J Gastroenterol Hepatol 2014; 26:114-118
43. Romano M, Cuomo A, Tuccillo C, Salerno R, Rocco A, Staibano S, et al. Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-Anal anastomosis. Dis Colon Rectum 2007; 50:650-659
44. Pellino G, Sciaudone G, Patturelli M, Candilio G, De Fatico GS, Landino I, et al. Relatives of Crohn's disease patients and breast cancer: an overlookedz: condition. Int J Surg 2014; Suppl 1:S156-S158
45. Selvaggi F, Pellino G, Canonico S, Sciaudone G. Systematic review of cuff and pouch cancer in patients with ileal pelvic pouch for ulcerative colitis. Inflamm Bowel Dis 2014; 20:1296-1308
46. Egan L, D'Inca R, Jess T, Pellino G, Carbonnel F, Bokemeyer B, et al. Noncolorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II). J Crohns Colitis 2014; 8:19-30
47. Scheinfeld N. Off-label uses and side effects of infliximab. J Drugs Dermatol 2004; 3:273-284